Shanghai Kaibao Pharmaceutical CO.,Ltd (SHE:300039)

China · Delayed Price · Currency is CNY

5.30

+0.15 (2.91%)

Sep 30, 2026, 3:04 PM CST

Market Cap	5.54B -12.4%
Revenue (ttm)	1.01B -19.0%
Net Income	258.56M -27.2%
EPS	0.25 -27.2%
Shares Out	1.05B
PE Ratio	21.44
Forward PE	n/a
Dividend	0.20 (3.77%)
Ex-Dividend Date	May 29, 2026

Volume	24,652,260
Open	5.22
Previous Close	5.15
Day's Range	5.14 - 5.31
52-Week Range	4.02 - 6.77
Beta	0.17
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 29, 2026

About SHE:300039

Shanghai Kaibao Pharmaceutical CO.,Ltd engages in the research, development, production, and sale of modern traditional Chinese medicines primarily in China. The company offers heat-clearing and detoxifying products, such as Tanreqing Injection for wind-heat in the lungs with phlegm-heat obstructing the lungs, early-stage pneumonia, acute bronchitis, acute exacerbations of chronic bronchitis, and respiratory infections; and Phlegm-Heat Clearing Capsules to clear heat, resolve phlegm, and detoxifying. It also provides liver-protecting products, ... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 2000

Employees 1,197

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 300039

Full Company Profile

Financial Performance

In 2025, SHE:300039's revenue was 1.15 billion, a decrease of -21.76% compared to the previous year's 1.47 billion. Earnings were 278.58 million, a decrease of -25.83%.

Financial Statements